infekt.ch

DIM-Journal Club: EBM

  • 19 März 2013 08:20

Ort: Konferenzzimmer Haus 01/U142
Referent: Susanne Angehrn

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07